218 related articles for article (PubMed ID: 18034599)
1. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Ronan Swords.
Swords R
Drugs; 2007; 67(17):2655-6. PubMed ID: 18034599
[No Abstract] [Full Text] [Related]
2. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Joseph Brandwein.
Brandwein J
Drugs; 2007; 67(17):2655. PubMed ID: 18034600
[No Abstract] [Full Text] [Related]
3. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Barbara Wassmann.
Wassmann B
Drugs; 2007; 67(17):2656. PubMed ID: 18034598
[No Abstract] [Full Text] [Related]
4. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ottmann OG; Wassmann B
Hematology Am Soc Hematol Educ Program; 2005; ():118-22. PubMed ID: 16304368
[TBL] [Abstract][Full Text] [Related]
5. Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib.
Tiribelli M; Sperotto A; Candoni A; Simeone E; Buttignol S; Fanin R
Leuk Res; 2009 Jan; 33(1):174-7. PubMed ID: 18471874
[TBL] [Abstract][Full Text] [Related]
6. Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ishii Y; Shoji N; Kimura Y; Ohyashiki K
Intern Med; 2006; 45(5):339-40. PubMed ID: 16596010
[No Abstract] [Full Text] [Related]
7. Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia.
Sanchez-Gonzalez B; Pascual-Ramirez JC; Fernandez-Abellan P; Belinchon-Romero I; Rivas C; Vegara-Aguilera G
Blood; 2003 Mar; 101(6):2446. PubMed ID: 12609964
[No Abstract] [Full Text] [Related]
8. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Fielding AK; Rowe JM; Richards SM; Buck G; Moorman AV; Durrant IJ; Marks DI; McMillan AK; Litzow MR; Lazarus HM; Foroni L; Dewald G; Franklin IM; Luger SM; Paietta E; Wiernik PH; Tallman MS; Goldstone AH
Blood; 2009 May; 113(19):4489-96. PubMed ID: 19244158
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.
Savani BN; Srinivasan R; Espinoza-Delgado I; Dorrance C; Takahashi Y; Igarashi T; Rezvani K; Lundqvist A; Barrett AJ; Childs RW
Lancet Oncol; 2005 Oct; 6(10):809-12. PubMed ID: 16198987
[No Abstract] [Full Text] [Related]
10. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
Czyz A; Lewandowski K; Kroll R; Komarnicki M
Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
[TBL] [Abstract][Full Text] [Related]
11. Imatinib for relapsed BCR/ABL positive leukemias.
Ottmann OG; Wassmann B; Hoelzer D
Ann Hematol; 2002; 81 Suppl 2():S36-7. PubMed ID: 12611069
[No Abstract] [Full Text] [Related]
12. Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion.
Tachibana T; Numata A; Tanaka M; Motohashi K; Fujisawa S; Fujita H; Sakai R; Tomita N; Maruta A; Ishigatsubo Y; Kanamori H
Leuk Lymphoma; 2011 Jul; 52(7):1376-9. PubMed ID: 21438838
[No Abstract] [Full Text] [Related]
13. Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Cross SA; Lyseng-Williamson KA
Drugs; 2007; 67(17):2645-54. PubMed ID: 18034597
[TBL] [Abstract][Full Text] [Related]
14. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
[TBL] [Abstract][Full Text] [Related]
15. Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation.
Kovacsovics T; Maziarz RT
Curr Oncol Rep; 2006 Sep; 8(5):343-51. PubMed ID: 16901395
[TBL] [Abstract][Full Text] [Related]
16. Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM.
De Vita S; De Matteis S; Laurenti L; Chiusolo P; Sorà F; Piccirillo N; Reddiconto G; Fiorini A; Leone G; Sica S
Ann Oncol; 2006 Apr; 17(4):720-1. PubMed ID: 16263757
[No Abstract] [Full Text] [Related]
17. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
[TBL] [Abstract][Full Text] [Related]
18. The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Zhang FH; Ling YW; Zhai X; Zhang Y; Huang F; Fan ZP; Zhou HS; Jiang QL; Sun J; Liu QF
Hematology; 2013 May; 18(3):151-7. PubMed ID: 23394269
[TBL] [Abstract][Full Text] [Related]
19. Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial.
Ribera JM; Oriol A; González M; Vidriales B; Brunet S; Esteve J; Del Potro E; Rivas C; Moreno MJ; Tormo M; Martín-Reina V; Sarrá J; Parody R; de Oteyza JP; Bureo E; Bernal MT; ;
Haematologica; 2010 Jan; 95(1):87-95. PubMed ID: 19797728
[TBL] [Abstract][Full Text] [Related]
20. A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Carpiuc KT; Stephens JM; Botteman MF; Feng W; Hay JW
Expert Opin Pharmacother; 2007 Nov; 8(16):2775-87. PubMed ID: 17956198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
